1
|
Brodin N, Conradsson DM, Swinnen TW, Esbensen BA, Kennedy N, Hammer NM, McKenna S, Henriksson P, Nordgren B. Self-report and device-based physical activity measures and adherence to physical activity recommendations: a cross-sectional survey among people with inflammatory joint disease in four European countries. BMJ Open 2023; 13:e064278. [PMID: 36746546 PMCID: PMC9906173 DOI: 10.1136/bmjopen-2022-064278] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/08/2023] Open
Abstract
OBJECTIVES Self-monitoring of physical activity (PA) has the potential to contribute to successful behaviour change in PA interventions in different populations, including people with inflammatory joint diseases (IJDs). The objectives of this study were to describe the use and knowledge of self-report-based and device-based PA measures in people with IJDs in four European countries, and to explore if the use of such devices, sociodemographic or disease-related variables were associated with adherence to the recommendations of at least 150 min of moderate to vigorous PA per week. SETTING Cross-sectional survey, performed in 2015-2016. PARTICIPANTS People with IJDs in Belgium, Denmark, Ireland and Sweden. PRIMARY AND SECONDARY OUTCOME MEASURES Use of self-report and device-based PA measures, receipt of instructions how to use PA measures, confidence in using them, adherence to PA recommendations and associated factors for adherence to PA recommendations. RESULTS Of the 1305 respondents answering questions on PA measures, 600 (46%) reported use of any kind of self-report or device-based measures to self-monitor PA. Between country differences of 34%-58% was observed. Six per cent and four per cent received instructions from health professionals on how to use simple and complex devices, respectively. Independent associated factors of fulfilment of recommendations of PA were living in Ireland (OR=84.89, p<0.001) and Sweden (OR=1.68, p=0.017) compared with living in Denmark, not perceiving activity limitations in moderate activities (OR=1.92, p<0.001) and using a device to measure PA (OR=1.56, p<0.001). Those living in Belgium (OR=0.21, p<0.001) were less likely to fulfil recommendations of PA. CONCLUSIONS Almost half of the participants with IJDs used self-report-based or deviced-based PA measures, although few used wearable devices regularly. The results indicate that participants meeting public PA health guidelines were engaged in self-monitoring of PA.
Collapse
Affiliation(s)
- N Brodin
- Department of Neurobiology Care Sciences and Society, Division of Physiotherapy, Karolinska Institutet, Stockholm, Sweden
- Division of Physiotherapy, Orthopaedic Clinic, Danderyds Sjukhus AB, Stockholm, Sweden
| | - David Moulaee Conradsson
- Department of Neurobiology Care Sciences and Society, Division of Physiotherapy, Karolinska Institutet, Stockholm, Sweden
- Medical Unit Occupational Therapy & Physiotherapy, Theme Women's Health and Allied Health Professional, Karolinska University Hospital, Stockholm, Sweden
| | - Thijs Willem Swinnen
- Department of Rehabilitation Sciences, KU Leuven, Leuven, Belgium
- Division of Rheumatology, KU Leuven University Hospitals Leuven, Leuven, Belgium
| | - Bente Appel Esbensen
- Copenhagen Center for Arthritis Research (Copecare), Copenhagen University Hospital - Rigshospitalet, Glostrup, Denmark
- Department of Clinical Medicine, University of Copenhagen, Kobenhavn, Denmark
| | - Norelee Kennedy
- Discipline of Physiotherapy, School of Allied Health, University of Limerick, Limerick, Ireland
- Health Research Institute, University of Limerick, Limerick, Ireland
| | - Nanna Maria Hammer
- Copenhagen Center for Arthritis Research (Copecare), Copenhagen University Hospital - Rigshospitalet, Glostrup, Denmark
| | - Sean McKenna
- Health Service Executive, Department of Physiotherapy, University of Limerick Hospitals Group, Dooradoyle, Ireland
| | - Peter Henriksson
- Department of Clinical Sciences, Danderyds Hospital, Karolinska Institutet, Stockholm, Sweden
| | - Birgitta Nordgren
- Department of Neurobiology Care Sciences and Society, Division of Physiotherapy, Karolinska Institutet, Stockholm, Sweden
- Medical Unit Occupational Therapy & Physiotherapy, Theme Women's Health and Allied Health Professional, Karolinska University Hospital, Stockholm, Sweden
| |
Collapse
|
2
|
Wang Y, Liu X, Wang W, Shi Y, Ji X, Hu L, Wang L, Yin Y, Xie S, Zhu J, Zhang J, Jiao W, Huang F. Adherence, Efficacy, and Safety of Wearable Technology-Assisted Combined Home-Based Exercise in Chinese Patients With Ankylosing Spondylitis: Randomized Pilot Controlled Clinical Trial. J Med Internet Res 2022; 24:e29703. [PMID: 35040798 PMCID: PMC8808346 DOI: 10.2196/29703] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2021] [Revised: 10/23/2021] [Accepted: 11/15/2021] [Indexed: 12/22/2022] Open
Abstract
Background Clinical practice guidelines recommend that exercise is essential in the self-management of ankylosing spondylitis (AS). Attending supervised interventions requiring periodic medical center visits can be difficult and patients may decline participation, whereas effective home-based exercise interventions that do not require regular medical center visits are likely to be more accessible for AS patients. Objective The goal of the research was to investigate the adherence, efficacy, and safety of a wearable technology–assisted combined home-based exercise program in AS. Methods This was a 16-week investigator-initiated, assessor-blinded, randomized, pilot controlled trial conducted at Chinese People’s Liberation Army General Hospital. We enrolled patients with AS who had no regular exercise habits and had been stable in drug treatment for the preceding month. Patients were randomly assigned (1:1) using a computer algorithm. An exercise program consisting of moderate-intensity aerobic exercise and functional exercise was given to the patients in the intervention group. The exercise intensity was controlled by a Mio FUSE Heart Rate Monitor wristband, which uses photoplethysmography to measure heart rate. Patients in the control group received usual care. The primary outcome was the difference in the Ankylosing Spondylitis Disease Activity Score (ASDAS). The secondary outcomes were patient global assessment (PGA), physician global assessment (PhGA), total pain, nocturnal pain, Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), BAS Functional Index (BASFI), BAS Metrology Index (BASMI), Spondyloarthritis International Society Health Index (ASAS HI), 36-item Short Form Survey (SF-36), maximal oxygen uptake (VO2) max, body composition, range of motion of joints, and muscle endurance tests. Retention rate, adherence rate, barriers to being active, and adverse events were also assessed. Results A total of 77 patients were screened, of whom 55 (71%) patients were enrolled; 2% (1/55) withdrew without treatment after randomization. Patients were assigned to the intervention (n=26) or control group (n=28). The median adherence rate of the prescribed exercise protocol was 84.2% (IQR 48.7%-97.9%). For the primary outcome, between-group difference of ASDAS was significant, favoring the intervention (–0.2, 95% CI –0.4 to 0.02, P=.03). For the secondary outcomes, significant between-group differences at 16 weeks were detected in PGA, PhGA, total pain, BASDAI, BASDAI-fatigue, BASDAI–spinal pain, BASDAI–morning stiffness intensity, BASFI, and BASMI. Moreover, the frequency of difficulty in ASAS HI-motivation at 16 weeks was less in the intervention group (P=.03). Between-group difference for change from baseline were also detected in VO2 max, SF-36, back extensor endurance test, and the range of motion of cervical lateral flexion at 16 weeks. Lack of time, energy, and willpower were the most distinct barriers to being active. Incidences of adverse events were similar between groups (P=.11). Conclusions Our pilot study suggests that this technology-assisted combined home-based exercise program can improve the clinical outcomes of patients with AS who have no exercise habit, with good adherence and safety profile. Trial Registration Chinese Clinical Trial Registry ChiCTR1900024244; http://www.chictr.org.cn/showproj.aspx?proj=40176
Collapse
Affiliation(s)
- Yiwen Wang
- Department of Rheumatology and Immunology, First Medical Center, Chinese People's Liberation Army General Hospital, Beijing, China
| | - Xingkang Liu
- Department of Rheumatology and Immunology, First Medical Center, Chinese People's Liberation Army General Hospital, Beijing, China.,College of Sport Medicine and Sport Rehabilitation, Beijing Sport University, Beijing, China
| | - Weimin Wang
- Health Management Institute, Second Medical Center, Chinese People's Liberation Army General Hospital, Beijing, China
| | - Yanyun Shi
- Health Management Institute, Second Medical Center, Chinese People's Liberation Army General Hospital, Beijing, China
| | - Xiaojian Ji
- Department of Rheumatology and Immunology, First Medical Center, Chinese People's Liberation Army General Hospital, Beijing, China
| | - Lidong Hu
- Department of Rheumatology and Immunology, First Medical Center, Chinese People's Liberation Army General Hospital, Beijing, China
| | - Lei Wang
- Department of Rheumatology and Immunology, First Medical Center, Chinese People's Liberation Army General Hospital, Beijing, China
| | - Yiquan Yin
- Advanced Research Institute of Olympic, Beijing Sport University, Beijing, China
| | - Siyuan Xie
- College of Sport Medicine and Sport Rehabilitation, Beijing Sport University, Beijing, China
| | - Jian Zhu
- Department of Rheumatology and Immunology, First Medical Center, Chinese People's Liberation Army General Hospital, Beijing, China
| | - Jianglin Zhang
- Department of Rheumatology and Immunology, First Medical Center, Chinese People's Liberation Army General Hospital, Beijing, China
| | - Wei Jiao
- College of Sport Medicine and Sport Rehabilitation, Beijing Sport University, Beijing, China
| | - Feng Huang
- Department of Rheumatology and Immunology, First Medical Center, Chinese People's Liberation Army General Hospital, Beijing, China.,National Clinical Research Center for Orthopedics, Sports Medicine and Rehabilitation, Chinese People's Liberation Army General Hospital, Beijing, China
| |
Collapse
|
3
|
Colas C, Goutte J, Creac'h C, Fontana L, Vericel MP, Manzanares J, Peuriere M, Akrour M, Martin C, Presles E, Barth N, Guyot J, Garros M, Trombert B, Massoubre C, Roche F, Féasson L, Marotte H, Cathebras P, Hupin D. Efficiency of an Optimized Care Organization in Fibromyalgia Patients: The From Intent to Move (FIMOUV) Study Protocol of a Randomized Controlled Trial. Front Public Health 2021; 9:554291. [PMID: 34113593 PMCID: PMC8185292 DOI: 10.3389/fpubh.2021.554291] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2020] [Accepted: 03/29/2021] [Indexed: 12/12/2022] Open
Abstract
Introduction: Fibromyalgia (FM) is characterized by multiple symptoms including pain, fatigue, and sleep disorders, altering patient's quality of life. In the absence of effective pharmacological therapy, the last European guidelines recommend a multidisciplinary management based on exercise and education. Thus, our main objective was to measure the effectiveness of a healthcare organization offering a specific program of adapted physical activity combined with a therapeutic education program for FM patients. Methods and Analysis: The From Intent To Move (FIMOUV) study will recruit 330 FM patients randomized into two groups: test and control. The test group will benefit from a 1-month mixed exercise training program supervised at the hospital, followed by 2 months in a community-based relay in a health-sport structure. In addition, each of the two groups will benefit from therapeutic patient education sessions. The main endpoint is the measurement of the level of physical activity by accelerometry at 1 year. The secondary endpoints concern adherence to the practice of physical activity, impact on lifestyle, state of health, and physical capacity, as well as an estimate of the budgetary impact of this management strategy. Discussion: This interventional research will allow us to assess the evolution of behaviors in physical activity after an FM syndrome management based solely on patient education or based on a supervised and adapted practice of physical activity associated with this same therapeutic education program. It seems to be the first study evaluating the impact of its intervention on objective data for measuring physical activity and sedentary behavior via accelerometry among FM patients. Trial registration:ClinicalTrials.gov NCT04107948.
Collapse
Affiliation(s)
- Claire Colas
- University Lyon, UJM-Saint-Etienne Sainbiose Laboratory, INSERM U1059, Saint-Étienne, France.,Department of Clinical and Exercise Physiology, University Hospital Center, Saint-Étienne, France
| | - Julie Goutte
- Department of Internal Medicine, University Hospital Center, Saint-Étienne, France
| | - Christelle Creac'h
- Pain Center, University Hospital Center, Saint-Étienne, France.,University Claude Bernard, Central Integration of Pain (NeuroPain) Lab-Lyon Neuroscience Research Center, INSERM U1028, CNRS, Bron, France
| | - Luc Fontana
- Department of Occupational and Environmental Medicine, University Hospital Center, Saint-Étienne, France.,University Lyon, University Lyon 1, University St Etienne, University Gustave Eiffel, IFSTTAR, UMRESTTE, UMR_T9405, Saint-Étienne, France
| | - Marie-Pierre Vericel
- Department of Clinical and Exercise Physiology, University Hospital Center, Saint-Étienne, France
| | | | - Marie Peuriere
- Clinical Research, Innovation and Pharmacology Unit, University Hospital Center, Saint-Étienne, France
| | - Madjid Akrour
- Clinical Research, Innovation and Pharmacology Unit, University Hospital Center, Saint-Étienne, France
| | - Charly Martin
- Clinical Research, Innovation and Pharmacology Unit, University Hospital Center, Saint-Étienne, France
| | - Emilie Presles
- University Lyon, UJM-Saint-Etienne Sainbiose Laboratory, INSERM U1059, Saint-Étienne, France.,Clinical Research, Innovation and Pharmacology Unit, University Hospital Center, Saint-Étienne, France.,Department of Clinical Investigation Center, CIC 1408-INSERM, University Hospital Center, Saint-Étienne, France
| | - Nathalie Barth
- University Lyon, UJM-Saint-Etienne Sainbiose Laboratory, INSERM U1059, Saint-Étienne, France.,University Lyon, UJM-Saint-Etienne Chaire Santé des Ainés, Saint-Étienne, France.,Gerontopole Auvergne-Rhone-Alpes, Saint-Étienne, France
| | - Jessica Guyot
- University Lyon, UJM-Saint-Etienne Sainbiose Laboratory, INSERM U1059, Saint-Étienne, France.,University Lyon, UJM-Saint-Etienne Chaire Santé des Ainés, Saint-Étienne, France
| | - Maël Garros
- Sport Health House, CDOS 42, Saint-Étienne, France
| | - Béatrice Trombert
- University Lyon, UJM-Saint-Etienne Sainbiose Laboratory, INSERM U1059, Saint-Étienne, France.,Department of Public Health, University Hospital Center, Saint-Étienne, France
| | | | - Frédéric Roche
- University Lyon, UJM-Saint-Etienne Sainbiose Laboratory, INSERM U1059, Saint-Étienne, France.,Department of Clinical and Exercise Physiology, University Hospital Center, Saint-Étienne, France
| | - Léonard Féasson
- Department of Clinical and Exercise Physiology, University Hospital Center, Saint-Étienne, France.,University Lyon, UJM-Saint-Etienne Interuniversity Laboratory of Human Movement Biology, EA 7424, Saint-Étienne, France
| | - Hubert Marotte
- University Lyon, UJM-Saint-Etienne Sainbiose Laboratory, INSERM U1059, Saint-Étienne, France.,Department of Rheumatology, University Hospital Center, Saint-Étienne, France
| | - Pascal Cathebras
- Department of Internal Medicine, University Hospital Center, Saint-Étienne, France
| | - David Hupin
- University Lyon, UJM-Saint-Etienne Sainbiose Laboratory, INSERM U1059, Saint-Étienne, France.,Department of Clinical and Exercise Physiology, University Hospital Center, Saint-Étienne, France.,Department of Medicine, K2, Solna Karolinska Institutet, Stockholm, Sweden
| |
Collapse
|